Albireo Pharma, Inc. (ALBO)
Company Info
| ISIN | US01345P1066 |
|---|---|
| CUSIP | 01345P106 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $37.13B |
|---|---|
| EPS | $0.91 |
| PE Ratio | 82.96 |
| PEG Ratio | 1.99 |
| Revenue (TTM) | $9.27B |
| Gross Profit (TTM) | $4.81B |
| EBITDA (TTM) | $2.11B |
| Year Range | $63.58 - $86.20 |
| Target Price | $88.47 |
| Short % | 1.52% |
| Short Ratio | 3.02 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Albireo Pharma, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | N/A | 19.67% |
| 1 month | N/A | 8.42% |
| 6 months | N/A | 7.29% |
| 1 year | N/A | 12.71% |
| 5 years (annualized) | N/A | 10.75% |
| 10 years (annualized) | N/A | 9.87% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -0.25% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Albireo Pharma, Inc. (ALBO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ALBO Albireo Pharma, Inc. | N/A | ||||
^GSPC S&P 500 | 0.91 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Albireo Pharma, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Albireo Pharma, Inc. was 99.77%, occurring on Dec 17, 2015. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.77% | Jan 10, 2008 | 1999 | Dec 17, 2015 | — | — | — |
| -32.88% | Jun 21, 2007 | 103 | Nov 14, 2007 | 26 | Dec 21, 2007 | 129 |
| -5.71% | Jun 4, 2007 | 5 | Jun 8, 2007 | 5 | Jun 15, 2007 | 10 |
| -3.02% | May 15, 2007 | 4 | May 18, 2007 | 4 | May 24, 2007 | 8 |
| -2.91% | Dec 28, 2007 | 3 | Jan 2, 2008 | 3 | Jan 7, 2008 | 6 |
Volatility Chart
The current Albireo Pharma, Inc. volatility is 2.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.